Vigilant Biosciences cleared to launch its oral cancer test across Europe

CEO Matthew H.J. Kim called the CE Marking a major milestone for the Fort Lauderdale-based life sciences company

Vigilant Biosciences CEO Matthew H.J. Kim is shown with scientific founder Dr. Elizabeth Franzmann, who is looking at a OncAlert point-of-care test prototype for an early detection system for risk of oral cancer. PATRICK FARRELL Miami Herald File Photo

BY NANCY DAHLBERG

 

Share

Facebook icon
Twitter icon
LinkedIn icon
Pinterest icon
e-mail icon